Your Complete Guide to the 2026 Winter Olympics

From medals to mascots, schedules to slopes—here’s everything you need to know to be ready for the 2026 Winter Olympic Games.

How Claude Code Is Reshaping Software—and Anthropic

WIRED spoke with Boris Cherny, head of Claude Code, about how the viral coding tool is changing the way Anthropic works.
Morningstar

Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive ...
Yahoo

Here’s how the solar eclipse affects dogs —and how to use the cosmic energy to optimize training

Dogs, like Geminis, get high on novelty and a walk through uncharted territory. On September 21, some of us will bear witness — but all of us will feel the pull of a partial solar eclipse in Virgo.
GitHub

Console input cursor does not reposition correctly after invalid input in Java program

When running a Java program in Eclipse IDE that uses Scanner.nextLine() for user input, the console fails to reposition the input cursor correctly after an exception or invalid input. Even though the ...
Business Wire

Vir Biotechnology Successfully Initiates all Trials in ECLIPSE Registrational Program for Chronic Hepatitis Delta

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...
Seeking Alpha

Vir Biotechnology Initiates Second Pivotal Trial in Its Global ECLIPSE Registrational Program for Chronic Hepatitis Delta

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...